Pulmonx Corp — Director's Dealing 2023

Oct 19, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2023-10-10

Reporting Person: McKune John (Interim CFO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	41356	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$2.20	2030-08-28	Common Stock (30050)		Direct
Employee Stock Option (right to buy)	$43.40	2031-05-31	Common Stock (13300)		Direct
Employee Stock Option (right to buy)	$26.56	2032-02-29	Common Stock (21500)		Direct
Employee Stock Option (right to buy)	$11.48	2033-02-28	Common Stock (17500)		Direct

Footnotes

F1: Includes 2,582, 6,063 and 22,400 Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on June 1, 2021, March 1, 2022 and March 1, 2023, respectively.

F2: The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date of August 24, 2020, and 1/36th of the remaining shares subject to the option vesting each month thereafter, subject to the Reporting Person's continuous service through each such vesting date.

F3: The shares subject to the option vest in 48 equal monthly installments beginning on June 1, 2021, subject to the Reporting Person's continuous service through each such vesting date.

F4: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2022, subject to the Reporting Person's continuous service through each such vesting date.

F5: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2023, subject to the Reporting Person's continuous service through each such vesting date.